Skip to main content
SpringerLink
Log in
Book cover
  • Book
  • © 2008

Hormonal Carcinogenesis V

Editors:

  1. Jonathan J. Li

    1. Medical Center Department of Pharmacology, University of Kansas, Kansas City, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Sara A. Li

    1. Medical Center Department of Pharmacology, University of Kansas, Kansas City, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Suresh Mohla

    1. Division of Cancer Biology, National Cancer Institute, Rockville, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Henri Rochefort

    1. Hormone and Cancer Unit, U540, Montpellier University and INSERM, Montpellier, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  5. Thierry Maudelonde

    1. Department of Cell Biology, Montpellier University 1-INSERM, U540 Hospital Arnaud de Villeneuve, Montpellier, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • A special emphasis will continue to be placed on the two major endocrine-related cancers, that is, breast and prostate.
  • Other highly relevant cancers to be addressed are ovarian and endometrial.
  • Emerging fields that will be examined are colon, lung, and pancreatic cancers in relation to hormones

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 617)

Sections

Buy it now

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (65 chapters)

  1. Front Matter

    Pages i-xlvi
    PDF

  3. State of the Art Speakers

    2. Ovarian Cancer: Linking Genomics to New Target Discovery and Molecular Markers — The Way Ahead

      • Bryan T. Hennessy, Mandi Murph, Meera Nanjundan, Mark Carey, Nelly Auersperg, Jonas Almeida et al.
      Pages 23-40

    3. Cdk1, Plks, Auroras, and Neks: The Mitotic Bodyguards

      • Patrick Salaun, Yoann Rannou, Prigent Claude
      Pages 41-56

  4. Celluar Origins of Endocrine-related Cancers

    1. Stem Cells, Hormones, and Mammary Cancer

      • Gilbert H. Smith
      Pages 69-78

    2. The Origin of Estrogen Receptor α-Positive and α-Negative Breast Cancer

      • Robert B. Clarke, Andrew H. Sims, Anthony Howell
      Pages 79-86

  6. New Developments in Steroid Receptor Interactions

    1. Regulation of Hormone Signaling by Nuclear Receptor Interacting Proteins

      • Vanessa Duong, Patrick Augereau, Eric Badia, Stéphan Jalaguier, Vincent Cavailles
      Pages 121-127

    2. Dynamics of Estrogen Receptor-mediated Transcriptional Activation of Responsive Genes In Vivo: Apprehending Transcription in Four Dimensions

      • Raphaël Métivier, Guillaume Huet, Rozenn Gallais, Laurence Finot, Fabien Petit, Christophe Tiffoche et al.
      Pages 129-138

    3. Expression of Estrogen Receptors α and β in Early Steps of Human Breast Carcinogenesis

      • Pascal Roger, Majida Esslimani-Sahla, Christophe Delfour, Gwendal Lazennec, Henri Rochefort, Thierry Maudelonde
      Pages 139-148

  7. Risk Assessment and Relevant Early Biomarkers

    3. Ovulation and Ovarian Cancer

      • Stephen G. Hillier, Michael T. Rae, Oliver Gubbay
      Pages 171-178

    4. Prostate Cancer Susceptibility Loci: Finding the Genes

      • Elanie A. Ostrander, Bo Johannesson
      Pages 179-190

  8. Novel Strategies for Preventing and Treatment of Endocrine-related Cancers

    1. Strategy for the Application of Therapy in Prostate Cancer

      • Christopher J. Logothetis
      Pages 193-199

    2. Response and Resistance to the Endocrine Prevention of Breast Cancer

      • Anthony Howell, Nigel J. Bundred, Jack Cuzick, D. Craig Allred, Robert Clarke
      Pages 201-211
Back to top

About this book

Information gathered from cell-free systems, cell cultures, animal models, and human studies, together will (1) provide important insights to our understanding of hormonal cancer causation, development, and prevention; (2) be the primary objective of these Symposia.

Back to top

Keywords

Back to top

Editors and Affiliations

  • Medical Center Department of Pharmacology, University of Kansas, Kansas City, USA

    Jonathan J. Li, Sara A. Li

  • Division of Cancer Biology, National Cancer Institute, Rockville, USA

    Suresh Mohla

  • Hormone and Cancer Unit, U540, Montpellier University and INSERM, Montpellier, France

    Henri Rochefort

  • Department of Cell Biology, Montpellier University 1-INSERM, U540 Hospital Arnaud de Villeneuve, Montpellier, France

    Thierry Maudelonde

Back to top

Bibliographic Information

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation